Sep 30, 2026 08:01AM
Sep 30, 2026 08:00AM
Aug 11, 2026 08:00AM
Aug 6, 2026 08:00AM
Aug 6, 2026 08:00AM
Jul 7, 2026 08:01AM
Jul 7, 2026 08:00AM Theriva™ Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients
Jun 11, 2026 08:01AM
Jun 11, 2026 08:00AM
May 5, 2026 04:30PM
May 8, 2025 04:30PM
May 7, 2025 09:20AM
May 7, 2025 09:17AM
Sep 27, 2024 06:03AM Theriva Biologics (TOVX) Prices 1.43M Share Offering at $1.75/sh
Sep 26, 2024 09:06PM
Mar 25, 2024 07:30AM
Aug 8, 2023 08:00AM
May 23, 2023 08:00AM
May 11, 2023 08:00AM
Mar 30, 2023 08:00AM
Nov 10, 2022 04:45PM Theriva Biologics Reports Third Quarter 2022 Operational Highlights and Financial Results
Oct 31, 2022 08:00AM
Oct 24, 2022 08:00AM
Oct 12, 2022 08:04AM
Oct 12, 2022 08:00AM

1,199,250 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All